![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 12, 2024 10:37:24 PM
One of the main differences between level 1 and level 2 trauma centers is that level 2 centers do not have the research and publication expectations of a level 1 center.
Recent ICU News
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders of SeaStar Medical Holding Corporation Should Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/19/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/15/2024 09:45:00 AM
- SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/13/2024 08:38:00 PM
- The Gross Law Firm Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Class Action Filed Against SeaStar Medical Holding Corporation (ICU) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
- CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial • GlobeNewswire Inc. • 07/16/2024 12:30:00 PM
- Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action • PR Newswire (US) • 07/12/2024 09:05:00 PM
- SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner • GlobeNewswire Inc. • 07/12/2024 12:30:00 PM
- SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/11/2024 08:05:00 PM
- SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/10/2024 01:00:00 PM
- SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device • GlobeNewswire Inc. • 07/03/2024 12:30:00 PM
- SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology • GlobeNewswire Inc. • 06/11/2024 12:30:00 PM
- SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation • GlobeNewswire Inc. • 06/07/2024 12:30:00 PM
- SeaStar Medical Announces 25-for-1 Reverse Stock Split • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility • GlobeNewswire Inc. • 05/22/2024 12:30:00 PM
- SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure • GlobeNewswire Inc. • 04/30/2024 12:30:00 PM
- SeaStar Medical Reports 2023 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 04/17/2024 08:00:00 PM
- SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- SeaStar Medical to Restate Financials, Sets Business Update Call for April 17 • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM